Biodegradable Polymers in Clinical Use and Clinical Development (Hardcover). Questo articolo non è disponibile.
Lingua: inglese
Editore: John Wiley & Sons Inc, New York, 2011
- Prima edizione
- Rilegato
- Nuovo

Da: AussieBookSeller, Truganina, VIC, AustraliaAussieBookSeller
Venditore AbeBooks dal 22 giugno 2007
Condizione: Nuovo
EUR 289,44
Descrizione dell’articolo da parte del venditore
Hardcover. This book focuses on biodegradable polymers that are already in clinical use or under clinical development. Synthetic and natural polymers will be included. This excludes polymers that have been investigated and did not reach clinical development. The purpose of this book is to provide updated status of the polymers that are clinical use and those that are now being developed for clinical use and hopefully will reach the clinic during the next 5 years. The book provides information that of interest to academics and practicing researchers including chemists, biologists and bioengineers and users: physicians, pharmacists. This book focuses on biodegradable polymers that are already in clinical use or under clinical development. Synthetic and natural polymers will be included. This excludes polymers that have been investigated and did not reach clinical development. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.
Codice articolo 9780470424759
- Titolo
- Biodegradable Polymers in Clinical Use and Clinical Development (Hardcover)
- Autore
- Abraham J. Domb
- Editore
- John Wiley & Sons Inc, New York
- Anno di pubblicazione
- 2011
- Condizione
- new
- Rilegatura
- Hardcover
- Lingua
- inglese
- ISBN 10
- 0470424753
- ISBN 13
- 9780470424759
- Edizione
- prima edizione
The purpose of this book is to provide updated status of the polymers that are clinical use and those that are now being developed for clinical use and hopefully will reach the clinic during the next 5 years. The book provides information that of interest to academics and practicing researchers including chemists, biologists and bioengineers and users: physicians, pharmacists.
"Riassunto" può appartenere a un’altra edizione di questo titolo.
Informazioni sull’autore
ABRAHAM J. DOMB is Professor of Medicinal Chemistry and Natural Products at the School of Pharmacy, the Hebrew University. Following time at Syntex Research in California, and MIT/Harvard as a research associate, he founded and headed the Drug Delivery and Polymer division at Nova Pharmaceuticals in Baltimore. Dr. Domb's primary research interests are in biopolymers, gene therapy, controlled drug delivery, cancer therapy, biodegradable polymers, hydrogels, coating of medical devices, nanoparticulate systems, and polymeric complexes.
NEERAJ KUMAR is Assistant Professor of Pharmaceutics at the National Institute of Pharmaceutical & Educational Research (NIPER), India. He obtained his PhD at the Indian Institute of Technology, Roorkee, India, before being appointed as Lady Davis Postdoctoral Fellow at the Hebrew University of Jerusalem. Dr. Kumar's current interests are in biomaterials, tissue engineering, drug delivery, and hydrogels.
AVIVA EZRA is a researcher at the Institute of Drug Research, School of Pharmacy, The Hebrew University of Jerusalem. She earned her PhD in pharmaceutics from the School of Pharmacy. Dr. Ezra's research interests include pharmaceutics, drug delivery systems, and pharmaceutical analysis.
"Descrizione articolo" può appartenere a un’altra edizione di questo titolo.